{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T22:15:41Z","timestamp":1770416141397,"version":"3.49.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Hunan Provincial Key Laboratory of Tumor Microenvironment Responsive Drug Research","award":["2019-56"],"award-info":[{"award-number":["2019-56"]}]},{"name":"Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.bioorg.2020.103652","type":"journal-article","created":{"date-parts":[[2020,2,5]],"date-time":"2020-02-05T00:28:34Z","timestamp":1580862514000},"page":"103652","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Synthesis and biological evaluation of novel 5,6,7-trimethoxy flavonoid salicylate derivatives as potential anti-tumor agents"],"prefix":"10.1016","volume":"96","author":[{"given":"Renbo","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangping","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yijiao","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanshi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Runde","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyong","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhizhong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guotao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2020.103652_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2007.10.002","article-title":"The biology of cancer: metabolic reprogramming fuels cell growth and proliferation","volume":"7","author":"Deberardinis","year":"2008","journal-title":"Cell Metab."},{"issue":"2018","key":"10.1016\/j.bioorg.2020.103652_b0010","first-page":"394","article-title":"Global cancer statistics 2018: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Freddie","year":"2018","journal-title":"Ca-Cancer J. Clin."},{"key":"10.1016\/j.bioorg.2020.103652_b0015","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1021\/acsnano.7b05108","article-title":"Nanotechnology strategies to advance outcomes in clinical cancer care","volume":"12","author":"Hartshorn","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioorg.2020.103652_b0020","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1021\/jacs.7b11468","article-title":"Addressing drug resistance in cancer with macromolecular chemotherapeutic agents","volume":"140","author":"Park","year":"2018","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2020.103652_b0025","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.ejmech.2017.10.021","article-title":"Dual or multi-targeting inhibitors: the next generation anticancer agents","volume":"143","author":"Raghavendra","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103652_b0030","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nchembio1108-648","article-title":"Killing two kinase families with one stone","volume":"4","author":"Bilanges","year":"2008","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bioorg.2020.103652_b0035","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1200\/JCO.2010.32.4145","article-title":"Activity of xl184 (cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer","volume":"29","author":"Kurzrock","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bioorg.2020.103652_b0040","first-page":"161","article-title":"Cheminform abstract: efficient synthesis and antiproliferative activity of novel thioether-substituted flavonoids","volume":"66","author":"Huang","year":"2013","journal-title":"Cheminform"},{"key":"10.1016\/j.bioorg.2020.103652_b0045","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ejmech.2009.09.041","article-title":"Antolovi\u0107, Structural aspects of flavonoids as inhibitors of human butyrylcholinesterase","volume":"45","author":"Katalini\u0107","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103652_b0050","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1039\/C4NJ02329C","article-title":"Synthesis, characterization and antioxidant activity of organoselenium and organotellurium compound derivatives of chrysin","volume":"39","author":"Fonseca","year":"2015","journal-title":"New J. Chem."},{"key":"10.1016\/j.bioorg.2020.103652_b0055","doi-asserted-by":"crossref","first-page":"204","DOI":"10.4046\/trd.2012.73.4.204","article-title":"Effect of chrysin on gene expression and production of muc5ac mucin from cultured airway epithelial cells","volume":"73","author":"Shin","year":"2012","journal-title":"Tub. Res. Dis."},{"key":"10.1016\/j.bioorg.2020.103652_b0060","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1111\/j.1365-2672.2011.05170.x","article-title":"Chrysin protects mice from Staphylococcus aureus pneumonia","volume":"111","author":"Wang","year":"2011","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.bioorg.2020.103652_b0065","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.bbrc.2009.02.071","article-title":"Chrysin, a natural flavone, improves murine inflammatory bowel diseases","volume":"381","author":"Shin","year":"2009","journal-title":"Biochem. Bioph. Res. Co."},{"key":"10.1016\/j.bioorg.2020.103652_b0070","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1016\/j.ejmech.2010.02.049","article-title":"A comparative study of flavonoid analogues on streptozotocin-nicotinamide induced diabetic rats: quercetin as a potential antidiabetic agent acting via 11\u03b2-hydroxysteroid dehydrogenase type 1 inhibition","volume":"45","author":"Torrespiedra","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103652_b0075","first-page":"333","article-title":"Evaluation of the anxiolytic effects of chrysin, a passiflora incarnata extract, in the laboratory rat","volume":"75","author":"Brown","year":"2007","journal-title":"Aana. J."},{"key":"10.1016\/j.bioorg.2020.103652_b0080","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.3390\/ijms11052188","article-title":"Apoptotic effects of chrysin in human cancer cell lines","volume":"11","author":"Yin","year":"2010","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2020.103652_b0085","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1055\/s-0030-1250457","article-title":"Effects of herbal supplements on drug glucuronidation. Review of clinical, animal, and in vitro studies","volume":"77","author":"Mohamed","year":"2011","journal-title":"Planta Med."},{"key":"10.1016\/j.bioorg.2020.103652_b0090","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.3892\/etm.2016.3518","article-title":"Vitexin attenuates acute doxorubicin cardiotoxicity in rats via the suppression of oxidative stress, inflammation and apoptosis and the activation of foxo3a","volume":"12","author":"Zhan","year":"2016","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.bioorg.2020.103652_b0095","doi-asserted-by":"crossref","first-page":"e601","DOI":"10.1038\/cddis.2013.131","article-title":"Oroxylin a induces dissociation of hexokinase ii from the mitochondria and inhibits glycolysis by sirt3-mediated deacetylation of cyclophilin d in breast carcinoma","volume":"4","author":"Wei","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bioorg.2020.103652_b0100","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1039\/C8NJ04533J","article-title":"Design, synthesis, and preliminary biological evaluation of 30,40,50-trimethoxy flavonoid salicylate derivatives as potential anti-tumor agents","volume":"43","author":"Deng","year":"2019","journal-title":"New J. Chem."},{"key":"10.1016\/j.bioorg.2020.103652_b0105","doi-asserted-by":"crossref","first-page":"103317","DOI":"10.1016\/j.bioorg.2019.103317","article-title":"Design and synthesis of substituted dihydropyrimidinone derivatives as cytotoxic and tubulin polymerization inhibitors","volume":"93","author":"Sravani","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2020.103652_b0110","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ejmech.2018.05.058","article-title":"Synthesis and biological evaluation of (1-aryl-1 h -pyrazol-4-yl) (3,4,5-trimethoxyphenyl)methanone derivatives as tubulin inhibitors","volume":"156","author":"Zhai","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103652_b0115","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ceb.2009.11.008","article-title":"From signaling pathways to microtubule dynamics: the key players","volume":"22","author":"Etiennemanneville","year":"2010","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.bioorg.2020.103652_b0120","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1038\/bjc.2014.76","article-title":"Tumour biomechanical response to the vascular disrupting agent ZD6126 in vivo assessed by magnetic resonance elastography","volume":"110","author":"Li","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bioorg.2020.103652_b0125","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.canlet.2014.09.038","article-title":"Dynamic bioluminescence and fluorescence imaging of the effects of the antivascular agent combretastatin-A4P (CA4P) on brain tumor xenografts","volume":"356","author":"Liu","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bioorg.2020.103652_b0130","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.clon.2004.11.011","article-title":"Vascular disrupting agents: a new class of drug in cancer therapy","volume":"17","author":"Gaya","year":"2005","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.bioorg.2020.103652_b0135","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1158\/1078-0432.CCR-0642-03","article-title":"Vascular targeting agents as cancer therapeutics","volume":"10","author":"Thorpe","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bioorg.2020.103652_b0140","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/sj.bjc.6605489","article-title":"Class III beta-tubulin expression and in vitro resistance to microtubule targeting agents","volume":"102","author":"Stengel","year":"2010","journal-title":"Brit. J. Cancer"},{"key":"10.1016\/j.bioorg.2020.103652_b0145","doi-asserted-by":"crossref","first-page":"7877","DOI":"10.1021\/acs.jmedchem.8b00827","article-title":"Structural modification of the 3,4,5-trimethoxyphenyl moiety in the tubulin inhibitor veru-111 leads to improved antiproliferative activities","volume":"61","author":"Wang","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103652_b0150","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.gtc.2010.08.010","article-title":"Nonsteroidal antiinflammatory drug-related injury to the gastrointestinal tract: clinical picture, pathogenesis, and prevention","volume":"39","author":"Scarpignato","year":"2010","journal-title":"Gastroenterol. Clin. N"},{"key":"10.1016\/j.bioorg.2020.103652_b0155","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.saa.2017.05.008","article-title":"Combination photodynamic therapy of human breast cancer using salicylic acid and methylene blue","volume":"184","author":"Hosseinzadeh","year":"2017","journal-title":"Spectrochim. Acta A"},{"key":"10.1016\/j.bioorg.2020.103652_b0160","first-page":"838","article-title":"The effects of acetylsalicylic acid on proliferation, apoptosis, and invasion of cyclooxygenase-2 negative colon cancer cells","volume":"32","author":"Yu","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103652_b0165","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bcp.2008.09.020","article-title":"Acetylsalicylic acid and salicylic acid decrease tumor cell viability and glucose metabolism modulating 6-phosphofructo-1-kinase structure and activity","volume":"77","author":"Spitz","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bioorg.2020.103652_b0170","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.toxlet.2015.01.008","article-title":"Chemopreventive and therapeutic potential of chrysin in cancer: mechanistic perspectives","volume":"233","author":"Kasala","year":"2015","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.bioorg.2020.103652_b0175","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/mnfr.201000269","article-title":"The p53, bax and p21 dependent inhibition of colon cancer cell growth by 5-hydroxy polymethoxyflavones","volume":"55","author":"Qiu","year":"2011","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.bioorg.2020.103652_b0180","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0165-6147(03)00026-9","article-title":"Cell-cycle dysregulation and anticancer therapy","volume":"24","author":"Pietenpol","year":"2003","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bioorg.2020.103652_b0185","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1021\/jm501997q","article-title":"Synthesis and biological evaluation of indolyl-pyridinyl-propenones having either methuosis or microtubule disruption activity","volume":"58","author":"Trabbic","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103652_b0190","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ccc.2010.12.013","article-title":"Lactate: biomarker and potential therapeutic target","volume":"27","author":"Okorie","year":"2011","journal-title":"Crit. Care Clin."},{"key":"10.1016\/j.bioorg.2020.103652_b0195","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1101\/gad.189365.112","article-title":"Links between metabolism and cancer","volume":"26","author":"Dang","year":"2012","journal-title":"Gene. Dev."},{"key":"10.1016\/j.bioorg.2020.103652_b0200","doi-asserted-by":"crossref","first-page":"9894","DOI":"10.1021\/acsnano.8b02813","article-title":"Targeting tumor microenvironment by bioreduction-activated nanoparticles for light-triggered virotherapy","volume":"12","author":"Tseng","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioorg.2020.103652_b0205","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrclinonc.2016.60","article-title":"Cancer metabolism: a therapeutic perspective","volume":"14","author":"Martinezoutschoorn","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bioorg.2020.103652_b0210","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/jnci\/82.1.4","article-title":"What is the evidence that tumors are angiogenesis dependent?","volume":"82","author":"Folkman","year":"1990","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bioorg.2020.103652_b0215","first-page":"3168","article-title":"Cancer therapeutic agents targeting hypoxia-inducible factor 1","volume":"18","author":"Wang","year":"2011","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.bioorg.2020.103652_b0220","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1517\/14728222.10.2.267","article-title":"Development of novel therapeutic strategies that target HIF-1","volume":"10","author":"Semenza","year":"2006","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.bioorg.2020.103652_b0225","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nrc2468","article-title":"Hypoxia, HIF1 and glucose metabolism in the solid tumour","volume":"8","author":"Denko","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bioorg.2020.103652_b0230","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1634\/theoncologist.9-90005-10","article-title":"The role of hypoxia-induced factors in tumor progression","volume":"9","author":"Vaupel","year":"2004","journal-title":"Oncologist"},{"key":"10.1016\/j.bioorg.2020.103652_b0235","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2174\/1389557515666150414152933","article-title":"Regulation of hypoxia-inducible factor-1\u03b1 and vascular endothelial growth factor signaling by plant flavonoids","volume":"15","author":"Fernando","year":"2015","journal-title":"Mini. Rev. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103652_b0240","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.biochi.2009.08.005","article-title":"Natural compounds and the hypoxia-inducible factor (HIF) signalling pathway","volume":"91","author":"Manolescu","year":"2009","journal-title":"Biochimie."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206819314099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206819314099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:02:45Z","timestamp":1758614565000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206819314099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":48,"alternative-id":["S0045206819314099"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.103652","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and biological evaluation of novel 5,6,7-trimethoxy flavonoid salicylate derivatives as potential anti-tumor agents","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.103652","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103652"}}